Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)

Wei Yan; Naga Rajiv Lakkaniga; Francesca Carlomagno; Massimo Santoro; Neil Q. Mcdonald; Fengping Lv; Naresh Gunaganti; Brendan Frett; Hong Yu Li

doi:10.1021/acs.jmedchem.0c01351

Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)

Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, Massimo Santoro, Neil Q. Mcdonald, Fengping Lv, Naresh Gunaganti, Brendan Frett, Hong Yu Li

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Page 1733. In Table 1, all citations of ref 108 should be replaced with a new reference SEER data. http://seer.cancer. gov.

Original language	English (US)
Pages (from-to)	10089
Number of pages	1
Journal	Journal of Medicinal Chemistry
Volume	63
Issue number	17
DOIs	https://doi.org/10.1021/acs.jmedchem.0c01351
State	Published - Sep 10 2020
Externally published	Yes

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

Access to Document

10.1021/acs.jmedchem.0c01351

Fingerprint

Dive into the research topics of 'Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)'. Together they form a unique fingerprint.

Cite this

Yan, W., Lakkaniga, N. R., Carlomagno, F., Santoro, M., Mcdonald, N. Q., Lv, F., Gunaganti, N., Frett, B., & Li, H. Y. (2020). Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092). Journal of Medicinal Chemistry, 63(17), 10089. https://doi.org/10.1021/acs.jmedchem.0c01351

Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092). / Yan, Wei; Lakkaniga, Naga Rajiv; Carlomagno, Francesca et al.
In: Journal of Medicinal Chemistry, Vol. 63, No. 17, 10.09.2020, p. 10089.

Research output: Contribution to journal › Comment/debate › peer-review

Yan, W, Lakkaniga, NR, Carlomagno, F, Santoro, M, Mcdonald, NQ, Lv, F, Gunaganti, N, Frett, B & Li, HY 2020, 'Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)', Journal of Medicinal Chemistry, vol. 63, no. 17, pp. 10089. https://doi.org/10.1021/acs.jmedchem.0c01351

Yan W, Lakkaniga NR, Carlomagno F, Santoro M, Mcdonald NQ, Lv F et al. Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092). Journal of Medicinal Chemistry. 2020 Sep 10;63(17):10089. doi: 10.1021/acs.jmedchem.0c01351

@article{9116561d9f2e441a9d5d81a303e4d1db,

title = "Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)",

abstract = "Page 1733. In Table 1, all citations of ref 108 should be replaced with a new reference SEER data. http://seer.cancer. gov.",

author = "Wei Yan and Lakkaniga, {Naga Rajiv} and Francesca Carlomagno and Massimo Santoro and Mcdonald, {Neil Q.} and Fengping Lv and Naresh Gunaganti and Brendan Frett and Li, {Hong Yu}",

year = "2020",

month = sep,

day = "10",

doi = "10.1021/acs.jmedchem.0c01351",

language = "English (US)",

volume = "63",

pages = "10089",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "17",

}

TY - JOUR

T1 - Correction

T2 - Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)

AU - Yan, Wei

AU - Lakkaniga, Naga Rajiv

AU - Carlomagno, Francesca

AU - Santoro, Massimo

AU - Mcdonald, Neil Q.

AU - Lv, Fengping

AU - Gunaganti, Naresh

AU - Frett, Brendan

AU - Li, Hong Yu

PY - 2020/9/10

Y1 - 2020/9/10

N2 - Page 1733. In Table 1, all citations of ref 108 should be replaced with a new reference SEER data. http://seer.cancer. gov.

AB - Page 1733. In Table 1, all citations of ref 108 should be replaced with a new reference SEER data. http://seer.cancer. gov.

UR - http://www.scopus.com/inward/record.url?scp=85090869495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090869495&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.0c01351

DO - 10.1021/acs.jmedchem.0c01351

M3 - Comment/debate

C2 - 32841014

AN - SCOPUS:85090869495

SN - 0022-2623

VL - 63

SP - 10089

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 17

ER -

Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this